PB2554: DESIGN OF A PHASE 1B OPEN-LABEL STUDY TO ASSESS THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT (ALPN-303) IN SUBJECTS WITH AUTOIMMUNE CYTOPENIAS (RUBY-4)

PB2554: DESIGN OF A PHASE 1B OPEN-LABEL STUDY TO ASSESS THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT (ALPN-303) IN SUBJECTS WITH AUTOIMMUNE CYTOPENIAS (RUBY-4)

Bibliographic Details
Main Authors:	Catherine M Broome, Donald Arnold, Caroline Piatek, Eun-Ju Lee, Hany Zayed, Stanford Peng, Ismail Simsek
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000976912.69182.0b

Similar Items

S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES
by: Stacey Dillon, et al.
Published: (2023-08-01)

P104 Upregulation of both APRIL and BAFF in systemic lupus erythematosus suggests non-redundant roles, further revealed by potent dual inhibition with povetacicept (TACI vTD-Fc; ALPN-303)
by: Amanda Enstrom, et al.
Published: (2024-03-01)

PO.6.131 A randomized, double-blind, placebo controlled study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-303, a potent dual baff/april inhibitor, in adult healthy volunteers
by: A Smith, et al.
Published: (2022-10-01)

Refractory Autoimmune Cytopenias Treated With Venetoclax
by: Max J. Gordon, et al.
Published: (2019-06-01)

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)

SARS-CoV-2 and Autoimmune Cytopenia
by: Ryann Quinn, et al.
Published: (2021-07-01)

Targeted treatment of autoimmune cytopenias in primary immunodeficiencies
by: Lucia Pacillo, et al.
Published: (2022-08-01)

Primary Sjogren’s syndrome presenting as autoimmune cytopenia
by: Durga Shankar Meena, et al.
Published: (2019-11-01)

Autoimmune Cytopenias In Common Variable Immunodeficiency (CVID)
by: Roshini Sarah Abraham, et al.
Published: (2012-07-01)

Autoimmune cytopenias related to common variable immunodeficiency
by: Vlasta Petric, et al.
Published: (2011-09-01)

Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single‐center, open‐label phase I trial
by: Kunhong Deng, et al.
Published: (2023-01-01)

Approaches to managing cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS).
by: V. Koneti eRao
Published: (2015-07-01)

Autoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant Patients
by: Jessica A. Neely, et al.
Published: (2019-05-01)

AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
by: Pavankumar Tandra, et al.
Published: (2013-11-01)

The effect of treatment with Campath-1H in patients with autoimmune cytopenias.
by: Willis, F, et al.
Published: (2001)

Systemic treatment for severe psoriasis in a patient with autoimmune cytopenia
by: Mary Kathryn Abel, et al.
Published: (2020-06-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
by: White, N, et al.
Published: (1999)

Pharmacokinetics and pharmacodynamics of curcumin.
by: Sharma, R, et al.
Published: (2007)

Secondary Hemophagocytic Lymphohistiocytosis and Autoimmune Cytopenias: Case Description and Review of the Literature
by: Bruno Fattizzo, et al.
Published: (2021-02-01)

Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort
by: Emma Westermann-Clark, et al.
Published: (2021-04-01)

Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update
by: Sanchi Chawla, et al.
Published: (2022-06-01)

Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets
by: Manuela Cortesi, et al.
Published: (2022-04-01)

Pharmacokinetic-pharmacodynamic modeling and simulation /
by: 192959 Bonate, Peter L.
Published: (2005)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Susanna Burckhardt, et al.
Published: (2011-01-01)

Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of danofloxacin in Lohi sheep
by: Z. Manzoor, et al.
Published: (2020-12-01)

Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity
by: Rubén Berrueco, et al.
Published: (2023-10-01)

Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience
by: Sanja Trajkova, et al.
Published: (2022-10-01)

Epidemiological profile, clinical, paraclinical, and evolutionary of adult autoimmune cytopenia cases in East of Algeria
by: Aziez Chettoum, et al.
Published: (2021-01-01)

Cytopenia and T cell proliferation.
by: Beverley, P, et al.
Published: (1982)

Refractory cytopenia of the childhood
by: M Chowdhry, et al.
Published: (2012-01-01)

Dimorphic anemia and cytopenias
by: Prita Pradhan
Published: (2019-01-01)

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
by: White, N
Published: (1994)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
by: White, N, et al.
Published: (1999)

Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
by: Lees, Peter, et al.
Published: (2003)

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
by: Koen G. A. M. Hussaarts, et al.
Published: (2020-08-01)

Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
by: Jinhai Wang, et al.
Published: (2021-10-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022-08-01)

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
by: Andrzej Czyrski, et al.
Published: (2021-11-01)

Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
by: Jeff D. Olivarez, et al.
Published: (2023-01-01)